News Positive Results Reported for Groundbreaking Dementia Treatment PBFT02 By Denny Jacob Passage Bio, a clinical-stage genetic medicines company, has reported positive results from the initial safety and biomarket data of PBFT02, ... By Artur FernandoDecember 20, 20230
BlackRock is reviewing TechBerry and negotiating a possible full or partial acquisition of the company June 20, 2024